ask="4.79"
ask_size="200"
average_daily_volume="796453"
bid="3.80"
bid_size="1000"
book_value="5.03"
change="-0.39"
change_from_200_day_moving_average="1.14"
change_from_50_day_moving_average="0.36"
change_from_52_week_high="-4.23"
change_From_52_week_low="2.62"
change_in_percent="-8.37%"
close="4.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.70"
eps_estimate_next_quarter="-0.84"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="9594000"
high="4.66"
high_52_weeks="8.50"
last_trade_date="2/28/2017"
last_trade_price="4.27"
last_trade_size="1049"
last_trade_time="4:00pm"
low="4.22"
low_52_weeks="1.65"
market_capitalization="62.28M"
moving_average_200_day="3.13"
moving_average_50_day="3.91"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="4.57"
pe_ratio="N/A"
peg_ratio="0.01"
percent_change_from_200_day_moving_average="+36.47%"
percent_change_from_50_day_moving_average="+9.07%"
percent_change_from_52_week_high="-49.76%"
percent_change_from_52_week_low="+158.79%"
previous_close="4.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.93"
price_per_sales="2.75"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="2.03"
stock_exchange="NMS"
symbol="OREX"
volume="567798"
weeks_range_52="1.65 - 8.50"
